Killip Classification Severity Tool for ACS

Clinical calculation support · Verify results before clinical use

Clinical classification

Select the highest Killip class supported by the patient's findings at presentation.

—Selected class
Killip class at presentation
IKillip class
Clinical severity at presentation

Class I · No clinical heart failure

No clinical signs of heart failure.
Clinical implication

Most favorable heart-failure profile among the four classes, but this does not imply low overall ACS risk. Assess the complete clinical picture.

Historical in-hospital mortality estimate: approximately 5–6% in the original-era cohort. This is not a contemporary individualized risk estimate.

How to interpret the Killip classification

The Killip classification is a bedside clinical classification of heart-failure severity in acute myocardial infarction/acute coronary syndrome (ACS). It uses examination findings to describe the degree of congestion or the presence of cardiogenic shock. It is a severity descriptor, not a stand-alone treatment algorithm or a substitute for validated global risk assessment.

Class definitions

ClassClinical findingsHistorical in-hospital mortality*
INo clinical heart failureApproximately 5–6%
IIMild heart failure: rales in limited lung fields, S3, and/or elevated JVPApproximately 15–20%
IIIAcute pulmonary edemaApproximately 35–40%
IVCardiogenic shock with hypotension and peripheral hypoperfusionHistorically greater than 80%

*Approximate historical estimates reported in early myocardial-infarction cohorts; case mix, reperfusion, supportive care, and contemporary systems of care differ. Do not use these percentages as current patient-specific predictions.

Practical use in ACS

  • Record findings at presentation and reassess if the patient's hemodynamic or respiratory status changes.
  • Class III findings indicate acute pulmonary edema; provide urgent assessment and respiratory/hemodynamic support as clinically indicated while treating the ACS.
  • Class IV findings indicate cardiogenic shock and require immediate escalation, urgent specialist/shock-team involvement, and evaluation for emergency coronary revascularization and appropriate circulatory support.
  • Use alongside ECG, biomarkers, hemodynamics, comorbidities, and validated risk tools. Do not delay emergency care to complete this tool.

References

Killip T, Kimball JT.Treatment of myocardial infarction in a coronary care unit: A two year experience with 250 patients. Am J Cardiol. 1967;20(4):457–464. DOI: 10.1016/0002-9149(67)90023-9. PMID: 6059183.
Rao SV, O'Donoghue ML, Ruel M, et al.2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2025;85(22):2135–2237. DOI: 10.1016/j.jacc.2024.11.009. PMID: 40013746.
Clinical disclaimer: This tool supports documentation and education. Killip class and historical mortality estimates must be interpreted in clinical context and are not individualized prognostic estimates. Clinical judgment and current ACS/shock protocols take precedence. Class III or IV findings may represent an emergency; initiate appropriate care and escalation without delay.